Arkansas Cardiology | Little Rock
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics (PK) of repeat doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 [COVID-19] POTS [post-COVID-POTS]).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
177 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Trial Registration Coordinator
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal